Gamgee Raises $4M Seed

Gamgee, a startup based in Australia, is developing an AI-powered platform to create personalized mRNA cancer vaccines for dogs. The company has secured $4 million in seed funding to scale its operations and accelerate the development of life-saving veterinary treatments.

Investors

The funding round was led by Founders Fund, with participation from Y Combinator, Celine Halioua, and Arash Ferdowsi.

Gamgee Use of Funds

Gamgee plans to use the capital to transition its personalized vaccine production into a SaaS-based industrialized production line. The funding will support clinical trials, the expansion of its end-to-end closed-loop platform, and efforts to reduce vaccine design time to under 48 hours while lowering treatment costs.

About Gamgee

Founded in 2026 by AI expert Paul Conyngham, Gamgee aims to cure cancer in dogs by bringing personalized mRNA cancer vaccines to the global market. The company utilizes a data-driven platform that integrates tumor sequencing, AI protein modeling, and automated vaccine design to provide rapid, targeted immunotherapy for canine patients.

Funding Details

Company Website: https://gamgee.io

Company: Gamgee
Raised: $4M
Round: Seed
Funding Date: August 2026
Lead Investor: Founders Fund
Additional Investors: Y Combinator, Celine Halioua, Arash Ferdowsi
Company Website: https://www.gamgee.io/
Software Category: Biotechnology
Source: https://www.kucoin.com/news/flash/ai-powered-dog-cancer-vaccine-startup-gamgee-secures-4m-seed-funding